XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2020     129,344,000          
Beginning balance at Dec. 31, 2020 $ 609,635 $ (378,138) $ 129 $ 1,030,577 $ (465,006) $ 1,530 $ (422,601) $ 86,868
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock in connection with equity offering, net of offering costs (in shares)     10,975,000          
Issuance of common stock upon exercise of stock options and ESPP 1,091,466   $ 11 1,091,455        
Equity component on conversions of 2023 notes and 2025 notes (236,920)     (236,920)        
Issuance of common stock upon conversions of 2023 notes (in shares)     2,983,000          
Issuance of common stock upon conversions of 2023 notes 235,521   $ 3 235,518        
Net proceeds from capped call related to conversions of 2023 notes and 2025 notes 67,769     67,769        
Issuance of common stock upon exercise of stock options and ESPP (in shares)     178,000          
Issuance of common stock upon exercise of stock options and ESPP 5,371     5,371        
Net share settlement of equity awards (in shares)     1,421,000          
Net share settlement of equity awards (89,337)   $ 2 (89,339)        
Share-based compensation expense 77,996     77,996        
Other comprehensive loss (3,082)         (3,082)    
Net income (25,764)           (25,764)  
Ending balance (in shares) at Sep. 30, 2021     144,901,000          
Ending balance at Sep. 30, 2021 1,354,517   $ 145 1,717,421   (1,552) (361,497)  
Beginning balance (in shares) at Jun. 30, 2021     144,621,000          
Beginning balance at Jun. 30, 2021 1,337,882   $ 145 1,706,855   (970) (368,148)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options and ESPP (in shares)     14,000          
Issuance of common stock upon exercise of stock options and ESPP 106     106        
Net share settlement of equity awards (in shares)     266,000          
Net share settlement of equity awards (14,697)     (14,697)        
Share-based compensation expense 25,157     25,157        
Other comprehensive loss (582)         (582)    
Net income 6,651           6,651  
Ending balance (in shares) at Sep. 30, 2021     144,901,000          
Ending balance at Sep. 30, 2021 $ 1,354,517   $ 145 1,717,421   (1,552) (361,497)  
Beginning balance (in shares) at Dec. 31, 2021 136,951,956   136,952,000          
Beginning balance at Dec. 31, 2021 $ 1,106,917   $ 137 1,449,305   (5,334) (337,191)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Repurchases of common stock (in shares)     (12,709,000)          
Repurchases of common stock (323,528)   $ (13) (323,515)        
Issuance of common stock in connection with equity offering, net of offering costs (in shares)     319,000          
Issuance of common stock upon exercise of stock options and ESPP 4,557     4,557        
Net share settlement of equity awards (in shares)     862,000          
Net share settlement of equity awards (12,775)   $ 1 (12,776)        
Share-based compensation expense 103,117     103,117        
Other comprehensive loss (96,536)         (96,536)    
Net income $ 264,780           264,780  
Ending balance (in shares) at Sep. 30, 2022 125,423,860   125,424,000          
Ending balance at Sep. 30, 2022 $ 1,046,532   $ 125 1,220,688   (101,870) (72,411)  
Beginning balance (in shares) at Jun. 30, 2022     126,344,000          
Beginning balance at Jun. 30, 2022 $ 818,791   $ 126 1,211,506   (68,868) (323,973)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Repurchases of common stock (in shares) (1,146,803)   (1,147,000)          
Repurchases of common stock $ (23,078)   $ (1) (23,077)        
Net share settlement of equity awards (in shares)     227,000          
Net share settlement of equity awards (2,555)     (2,555)        
Share-based compensation expense 34,814     34,814        
Other comprehensive loss (33,002)         (33,002)    
Net income $ 251,562           251,562  
Ending balance (in shares) at Sep. 30, 2022 125,423,860   125,424,000          
Ending balance at Sep. 30, 2022 $ 1,046,532   $ 125 $ 1,220,688   $ (101,870) $ (72,411)